Tango Therapeutics, Inc.
NASDAQ:TNGX · NASDAQ Global Market
-$3.24 today
Vol 11.81M · Avg 3.67M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+425.75%
Period High
$32.90
Period Low
$4.92
Latest
$27.97
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kodiak Sciences Inc.
NASDAQ:KOD
$1.90B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.62B
Septerna, Inc.
NASDAQ:SEPN
$1.59B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.49B
Fortrea Holdings Inc.
NASDAQ:FTRE
$1.47B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.25B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.14B
Xencor, Inc.
NASDAQ:XNCR
$946.79M
Kura Oncology, Inc.
NASDAQ:KURA
$858.00M
ProKidney Corp.
NASDAQ:PROK
$262.71M
What is the latest TNGX filing?
The latest filing shown is FWP dated Jun 10, 2026.
How many recent filings does TNGX have?
Intrinsic Alpha currently shows 20 recent filings for TNGX.
Explore More
Continue the stock analysis
Jump to another research area for this company.